Farmaceutica REMEDIA Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	12.1	6.96	7.2	5.81	7.23	37.77
Depreciation & Amortization	1.67	2.63	5.06	4.02	1.11	0.98
Other Amortization	-	-	-	-	0.09	0.1
Other Operating Activities	16.94	9.37	10.96	-11.81	-5.8	-52.37
Operating Cash Flow	30.71	18.96	23.22	-1.99	2.63	-13.52
Operating Cash Flow Growth	159.20%	-18.34%	-	-	-	-
Capital Expenditures	-2.59	-1.79	-1.38	-0.04	-0.04	-0.08
Sale of Property, Plant & Equipment	0.11	0.35	0.35	0.2	0.48	39.9
Other Investing Activities	2	2.06	0.07	0.08	0.14	0.07
Investing Cash Flow	-0.48	0.62	-0.97	0.24	0.58	39.89
Short-Term Debt Issued	-	-	-	-	-	18.5
Total Debt Issued	-	-	-	-	-	18.5
Short-Term Debt Repaid	-	-	-	-	-	-18.82
Total Debt Repaid	-	-	-	-	-	-18.82
Net Debt Issued (Repaid)	-	-	-	-	-	-0.32
Repurchase of Common Stock	-0.57	-	-1.5	-	-	-
Common Dividends Paid	-5.35	-6.29	-4.19	-4.47	-13.35	-1.99
Other Financing Activities	-0.19	-0.14	-0	-0.05	0.01	0.02
Financing Cash Flow	-6.1	-6.43	-5.7	-4.52	-13.35	-2.29
Miscellaneous Cash Flow Adjustments	-	-0	-0.14	0.14	-	-0
Net Cash Flow	24.13	13.16	16.41	-6.13	-10.13	24.07
Free Cash Flow	28.12	17.17	21.84	-2.03	2.59	-13.6
Free Cash Flow Growth	169.48%	-21.36%	-	-	-	-
Free Cash Flow Margin	3.73%	2.31%	3.68%	-0.38%	0.54%	-3.08%
Free Cash Flow Per Share	0.24	0.18	0.23	-0.02	0.03	-0.13
Cash Interest Paid	-	-	-	0.07	-	0.1
Cash Income Tax Paid	6.93	5.31	1.61	1.29	1.55	5.01
Levered Free Cash Flow	30.44	19.84	21.82	1.54	10.32	-2.41
Unlevered Free Cash Flow	30.47	19.9	21.9	1.64	10.39	-2.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.